Merck is the most exposed to risk from generic competition in the short term, but AbbVie, Johnson & Johnson, Sanofi and ...
The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...
The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.
Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.
The pharma and biotech industries are constantly in flux. Every year, pharma professionals converge on a number of large ...
Alveus, Lilly, Viking and Amgen are testing maintenance strategies as durability becomes a bigger focus in obesity R&D.
Dr. John Tsai grabbed the reins of global R&D this year with a clear mandate: extend Daiichi’s oncology momentum beyond its ...
Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...
The FDA is continuing its push to expedite early-stage research for drug developers and is now accepting applications for a new pilot program aimed at accelerating U.S. clinical trials. The primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results